| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326780 | Gynecologic Oncology | 2005 | 14 Pages |
Abstract
Offering palliative chemotherapy to patients with advanced, unresectable uterine sarcoma who are symptomatic from this disease is a reasonable decision. Doxorubicin is an option for women with advanced uterine sarcoma. The combination of cisplatinum and ifosfamide is also an option for women with metastatic mixed mesodermal tumors; however, this combination is associated with significant toxicity when compared to ifosfamide alone.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sindu Kanjeekal, Alexandra Chambers, Michael Fung Kee Fung, Shailendra Verma,